GLOBEALERT
HEALTHLOWAug 20 · Aug 20, 2026, 1:00 PM

Nuvation granted Fast Track status for safusidenib for brain tumors

Seeking Alpha Tech

Nuvation has received Fast Track status for safusidenib, a potential treatment for brain tumors. This status aims to expedite the development and review of drugs for serious conditions.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Health